Aim

In recognition of the critical role that Patient and Public Involvement (PPI) plays in shaping effective and relevant research, we are offering a PPI seed fund of up to £300 to support meaningful engagement activities in the field of prostate cancer. This initiative aims to bridge the gap between research and real-world patient experiences, ensuring that our work remains both impactful and aligned with patient needs.

Each application will be evaluated on a case-by-case basis.

Scope

The PCR PPI Seed Funding is designed to:
  • Facilitate activities such as meeting attendance involving patients, preparation and printing posters, involving patients as consultants, covering snacks and catering, meeting room costs, and workshop expenses for public involvement.
  • Encourage research projects that actively involve patients and the public from the outset.
  • Foster collaboration between researchers, patients, and public stakeholders.
Funding Criteria
  • Funding: Up to £300
Eligibility
  • Applicant(s) must be based at an eligible UK academic or research institutions or hospitals.
  • Applicant(s) should be researchers involved in Prostate Cancer.
  • Early career researchers and PhD students are encouraged to apply.
Key Considerations
  • Clearly articulate the purpose of engaging with patients and the public.
  • Identify specific groups you intend to engage and provide a rationale for their involvement.
  • Outline strategies for connecting with these groups.
  • Apply Equity, Diversity, and Inclusion (EDI) principles to value differences and ensure inclusivity.
How to apply
  • The PCR PPI Seed Fund operates as a rolling scheme, meaning there are no fixed deadlines — you can apply at any time throughout the year.
  • Applications are reviewed on a quarterly basis, and funding decisions are issued shortly after each review cycle.
  • We encourage you to submit your application as soon as your project idea is ready.
  • All submissions will be considered in the next available review period.
  • If your application is received just after a review point, it will be held for the following cycle.
To be considered for a funding decision in December 2025, applications must be received by 23:59 on Friday 14 November 2025. Applications submitted after this date will be reviewed in the next cycle, with funding decisions announced in Spring 2026.

T